Pretty impressive meeting with SI smashing all with data.
Well done all who asked questions
Huge positive results for Revascor PRDD from randomised control trial. (Publication coming out very soon )…
Same with Back
Very confident in SR- aGVHD.
Very confident in Adult aGVHD.
Cells work!
Money - chasing partnership , cannot predict, back pain and Heart space partners looking good…Advanced but seems dependant on FDA tick.
FDA wants improved potency assay. Product is consistent. Hopefully , should be enough to release product with children.
Parallel strategy going on. Next meeting , next quarter ..
Thanks for asking about availability to children.. VERY IMPORTANT ANSWER. THEY ARE .Cells work. Parents, doctors Kids everyone sees the value… WHY NOT FDA. Why holding up approval….
Again , whoever asked the question, please let me know but thanks..
ok… i have to head back to work so ill post this
Ann: CEO Presentation to 2023 Annual General Meeting, page-3
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |